Sign In
Buy KALA
$3.54
-0.0700 (-1.94%)
At Close: Jun 22, 2026
CVS Health To $120? Here Are 5 Other Price Target Changes For Monday
11:25am, Monday, 15'th Aug 2022 Benzinga
Mizuho raised the price target on CVS Health Corporation (NYSE: CVS) from $115 to $120. Mizuho analyst Ann Hynes maintained the stock with a Buy rating. CVS Health shares fell 0.4% to $106.00 in pre-
Kala Pharmaceuticals, Inc. (KALA) CEO Mark Iwicki on Q2 2022 Results - Earnings Call Transcript
07:51pm, Friday, 12'th Aug 2022
Kala Pharmaceuticals, Inc. (NASDAQ:KALA ) Q2 2022 Earnings Conference Call August 11, 2022 8:00 AM ET Company Participants Hannah Deresiewicz – Stern Investor Relations Mark Iwicki – Chief Executi
Kala Pharmaceuticals (KALA) Reports Q2 Loss, Misses Revenue Estimates
12:15pm, Thursday, 11'th Aug 2022 Zacks Investment Research
Kala Pharma (KALA) delivered earnings and revenue surprises of 13.64% and 18.13%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Kala Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate Update
11:00am, Thursday, 11'th Aug 2022 GlobeNewswire Inc.
-- Plan to Initiate Phase 2/3 Trial of KPI-012 for Persistent Corneal Epithelial Defect (PCED) in 4Q 2022; Topline Data Expected in 1Q 2024 ---- Received $60M Upfront Payment from Sale of EYSUVIS® an
Kala Pharmaceuticals (KALA) Reports Q2 Loss, Misses Revenue Estimates
09:47am, Thursday, 11'th Aug 2022
Kala Pharma (KALA) delivered earnings and revenue surprises of 13.64% and 18.13%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
AquaBounty Technologies, Inc. (AQB) Reports Q2 Loss, Misses Revenue Estimates
01:35pm, Tuesday, 09'th Aug 2022 Zacks Investment Research
AquaBounty Technologies, Inc. (AQB) delivered earnings and revenue surprises of 11.11% and 12.30%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the s
Kala Pharmaceuticals to Participate in Upcoming Investor Conferences in August
04:01pm, Thursday, 04'th Aug 2022
ARLINGTON, Mass., Aug. 04, 2022 (GLOBE NEWSWIRE) -- Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a clinical-stage biopharmaceutical company dedicated to the research, development and commercialization of
Kala Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
08:01pm, Friday, 22'nd Jul 2022 GlobeNewswire Inc.
ARLINGTON, Mass., July 22, 2022 (GLOBE NEWSWIRE) -- Kala Pharmaceuticals, Inc. (NASDAQ:KALA), today announced that the Company granted non-statutory stock options to a new employee as an inducement
Kala Pharmaceuticals Completes Sale of EYSUVIS® and INVELTYS® to Alcon Inc
12:00pm, Monday, 11'th Jul 2022 GlobeNewswire Inc.
ARLINGTON, Mass, July 11, 2022 (GLOBE NEWSWIRE) -- Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a clinical-stage biopharmaceutical company dedicated to the research, development and commercialization o
Kala Pharma (KALA) Moves to Buy: Rationale Behind the Upgrade
04:00pm, Wednesday, 06'th Jul 2022 Zacks Investment Research
Kala Pharma (KALA) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Kala Pharma (KALA) Moves to Buy: Rationale Behind the Upgrade
01:13pm, Wednesday, 06'th Jul 2022
Kala Pharma (KALA) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Kala Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
08:01pm, Friday, 17'th Jun 2022 GlobeNewswire Inc.
ARLINGTON, Mass., June 17, 2022 (GLOBE NEWSWIRE) -- Kala Pharmaceuticals, Inc. (NASDAQ:KALA), today announced that the Company granted non-statutory stock options to new employees as inducement awar
Kala Pharmaceuticals to Present at Jefferies Healthcare Conference
12:00pm, Thursday, 02'nd Jun 2022 GlobeNewswire Inc.
ARLINGTON, Mass., June 02, 2022 (GLOBE NEWSWIRE) -- Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a commercial-stage biopharmaceutical company focused on the discovery, development and commercialization
Kala Pharmaceuticals to Present at Jefferies Healthcare Conference
08:00am, Thursday, 02'nd Jun 2022
ARLINGTON, Mass., June 02, 2022 (GLOBE NEWSWIRE) -- Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a commercial-stage biopharmaceutical company focused on the discovery, development and commercialization o
Penny Stocks To Buy Now? 4 To Watch Under $1
01:34pm, Monday, 23'rd May 2022 PennyStocks
Penny stocks under $1 to watch right now.
The post Penny Stocks To Buy Now? 4 To Watch Under $1 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
